PRELUDE CAPITAL MANAGEMENT, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 121 filers reported holding CARA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.47 and the average weighting 0.6%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,000
-83.3%
93
-80.6%
0.00%
Q4 2018$6,0000.0%479
+19.8%
0.00%
-100.0%
Q2 2017$6,000
-96.5%
400
-97.8%
0.00%
-95.2%
Q4 2016$172,000
+473.3%
18,521
+278.0%
0.02%
+425.0%
Q1 2016$30,000
-64.3%
4,900
-2.0%
0.00%
-69.2%
Q4 2015$84,000
+71.4%
5,000
+47.1%
0.01%
+85.7%
Q3 2015$49,0003,4000.01%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 622,140$10,489,00045.13%
RHO CAPITAL PARTNERS INC 2,668,057$44,983,00015.47%
Opaleye Management Inc. 427,000$7,199,0003.01%
DAFNA Capital Management LLC 169,331$2,855,0002.54%
Private Capital Advisors, Inc. 246,850$4,162,0001.80%
WALL STREET ASSOCIATES 192,300$3,242,0000.91%
SECTORAL ASSET MANAGEMENT INC 1,212,578$20,444,0000.87%
Virtus ETF Advisers LLC 17,299$292,0000.80%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 618,140$10,422,0000.58%
SPHERA FUNDS MANAGEMENT LTD. 197,820$3,335,0000.49%
View complete list of CARA THERAPEUTICS INC shareholders